Eric Van Belle

Showing 1-4 of 4 articles

Interventions for valvular disease

Transaxillary compared with transcarotid access for TAVR: a propensity-matched comparison from a French multicenter registry

Debry N, Trimech TR, Gandet T, Vincent F, Hysi I, Delhaye C, Cayla G, Koussa M, Juthier F, Leclercq F, Pécheux M, Ghostine S, Labreuche J, Modine T, Van Belle E, Bical A, Denimal T, Pamart T, Spillemaeker H, Verdier B, Cosenza A, Coisne A, Porouchani S, Sudre A, Mugnier A, Rousse N, Loobuyck V, Vincentelli A, Macia JC, Akodad M, Fabre O, Gommeaux A, Schmutz L, Moussa MD, Robin E, Azmoun A

May 29, 2020 | 10.4244/EIJ-D-20-00117

Interventions for valvular disease

Transcatheter mitral valve replacement: factors associated with screening success and failure

Coisne A, Pontana F, Tchétché D, Richardson M, Longère B, Vahdat O, Berthoumieu P, Van Belle E, Rousse N, Lancellotti P, Montaigne D, Dumonteil N, Modine T

December 6, 2019 | 10.4244/EIJ-D-19-00444

Interventions for valvular disease

Urgent balloon aortic valvuloplasty in patients with cardiogenic shock related to severe aortic stenosis: time matters

Debry N, Kone P, Vincent F, Lemesle G, Delhaye C, Schurtz G, Spillemaeker H, Porouchani S, Coisne A, Auffray J-L, Sudre A, Lamblin N, Bonello L, Van Belle E

August 3, 2018 | 10.4244/EIJ-D-18-00029

Stent for Life in France

Gilard M, Fajadet J, Belle L, Carrié D, Cottin Y, Ducasse J-L, Dujardin J-J, Freysz M, Garot P, Goldstein P, Le Breton H, Lefèvre T, Savary D, Ta T, Van Belle E

August 25, 2012 | 10.4244/EIJV8SPA13

1

Latest news

LM revascularisation, annulus rupture, risk stratification, renal denervation

Ahead of print: The Impact of COVID-19 on Interventional Cardiology Practice: Results of the EAPCI Survey

Marco Roffi, Dariusz Dudek, et al.

A perspective from EAPCI Women and Women as One

Gill Louise Buchanan

Last Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

Guidance Papers

Guidelines, consensus & position papers

EuroIntervention new Editorial Board

This week’s JAA’s: Paradigm Study: 12months outcome, GLASSY ACS vs SIHD...

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke